Advertisement

Oncology

A new artificial intelligence algorithm can accurately assess the risk of cancer associated with indeterminate pulmonary nodules in patients' lungs, according to a study published in American Journal of Respiratory and Critical Care Medicine.

Advertisement

AstraZeneca will start a clinical trial to see if its cancer drug Calquence can suppress the excessive immune response COVID-19 triggers in some patients, the drugmaker said April 14.

Advertisement